CARLSBAD, Calif.--(BUSINESS WIRE)--Brendan Technologies, Inc. (OTCBB: BDTE), an analytical software company developing advanced commercial software for immunoassay and bioassay testing technologies, has secured a bridge financing totaling $600,000, led by Little Bear Investments LLC as the lead investor and facilitated by Midtown Partners & Co. LLC.
